First-in-human study attacks inoperable pancreatic tumors with laser light

Дата публикации: 11-09-2026 16:40:04

UCI Health, the clinical enterprise of the University of California, Irvine, is conducting a first-in-human, Phase I clinical trial using laser light to target localized but inoperable pancreatic tumors to help patients become cancer-free.

Основное содержимое страницы с новостью.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	Combined nanoparticle and internal laser method could make cancer therapy less invasive	0	7.19	22-07-2026
2	Cancer du pancréas : une première européenne au CHU Grenoble Alpes	0	5	12-05-2026
3	Blood test shows promise for detecting pancreatic cancer at its earliest stages	0	5.07	16-09-2026
4	New targeted therapy shows promising early results in advanced pancreatic cancer	2	7	05-07-2026
5	New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer	5	7	02-07-2026
6	Smart nanoparticles light up brain cancer and destroy what surgery misses	0	10.41	27-08-2026
7	Ученые томского вуза начали испытания новой для РФ методики терапии неоперабельного рака	0	0	14-10-2020
8	Vaccine may ‘intercept’ pancreatic cancer before it starts	0	13.27	16-07-2026
9	Tumor on a chip reveals how pancreatic cancer hijacks immune cells in real time	5	8	07-07-2026

Классификация: Наука. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 11.24. Источник: medicalxpress.com.